Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice
Alina Neunkirchner,
Bernhard Kratzer,
Cordula Köhler,
Ursula Smole,
Lukas F. Mager,
Klaus G. Schmetterer,
Doris Trapin,
Victoria Leb-Reichl,
Edward Rosloniec,
Ronald Naumann,
Lukas Kenner,
Beatrice Jahn-Schmid,
Barbara Bohle,
Rudolf Valenta,
Winfried F. Pickl
Affiliations
Alina Neunkirchner
Christian Doppler Laboratory for Immunomodulation, 1090 Vienna, Austria; Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Bernhard Kratzer
Christian Doppler Laboratory for Immunomodulation, 1090 Vienna, Austria; Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Cordula Köhler
Christian Doppler Laboratory for Immunomodulation, 1090 Vienna, Austria; Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Ursula Smole
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Lukas F. Mager
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Klaus G. Schmetterer
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria
Doris Trapin
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Victoria Leb-Reichl
Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria
Edward Rosloniec
Department of Medicine, University of Tennessee Health Science Center, Memphis, 38163, TN, USA; Memphis Veterans Affairs Medical Center, 38104, TN, USA; Department of Pathology, University of Tennessee Health Science Center, Memphis, 38163, TN, USA
Ronald Naumann
Max Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany
Lukas Kenner
Department of Laboratory Animal Pathology, Medical University of Vienna, 1090 Vienna, Austria; Department of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria
Beatrice Jahn-Schmid
Department of Pathophysiology and Allergy Research, Medical University of Vienna, 1090 Vienna, Austria
Barbara Bohle
Christian Doppler Laboratory for Immunomodulation, 1090 Vienna, Austria; Department of Pathophysiology and Allergy Research, Medical University of Vienna, 1090 Vienna, Austria
Rudolf Valenta
Department of Pathophysiology and Allergy Research, Medical University of Vienna, 1090 Vienna, Austria
Winfried F. Pickl
Christian Doppler Laboratory for Immunomodulation, 1090 Vienna, Austria; Institute of Immunology, Medical University of Vienna, 1090 Vienna, Austria; Corresponding author at: Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Lazarettgasse 19, 1090 Vienna, Austria.
Background: Immunoglobulin(Ig)E-associated allergies result from misguided immune responses against innocuous antigens. CD4+ T lymphocytes are critical for initiating and perpetuating that process, yet the crucial factors determining whether an individual becomes sensitized towards a given allergen remain largely unknown. Objective: To determine the key factors for sensitization and allergy towards a given allergen. Methods: We here created a novel human T cell receptor(TCR) and human leucocyte antigen (HLA)-DR1 (TCR-DR1) transgenic mouse model of asthma, based on the human-relevant major mugwort (Artemisia vulgaris) pollen allergen Art v 1 to examine the critical factors for sensitization and allergy upon natural allergen exposure via the airways in the absence of systemic priming and adjuvants. Results: Acute allergen exposure led to IgE-independent airway hyperreactivity (AHR) and T helper(Th)2-prone lung inflammation in TCR-DR1, but not DR1, TCR or wildtype (WT) control mice, that was alleviated by prophylactic interleukin(IL)-2-αIL-2 mAb complex-induced expansion of Tregs. Chronic allergen exposure sensitized one third of single DR1 transgenic mice, however, without impacting on lung function. Similar treatment led to AHR and Th2-driven lung pathology in >90% of TCR-DR1 mice. Prophylactic and therapeutic expansion of Tregs with IL-2-αIL-2 mAb complexes blocked the generation and boosting of allergen-specific IgE associated with chronic allergen exposure. Conclusions: We identify genetic restriction of allergen presentation as primary factor dictating allergic sensitization and disease against the major pollen allergen from the weed mugwort, which frequently causes sensitization and disease in humans. Furthermore, we demonstrate the importance of the balance between allergen-specific T effector and Treg cells for modulating allergic immune responses. Keywords: Sensitization, Airway hyperreactivity, T regulatory cells, IL-2-αIL-2 complexes, Allergen-specific TCR, Tolerance, Aeroallergen, Mugwort allergy